Most startups that raise money never return it. When they wind down, the cap table is worth zero and the bank account is empty. The patents are frequently the only asset left that has a buyer on the other side.
What happens to IP when a startup shuts down: it stops belonging to the founders and becomes a creditor asset. The moment a company is insolvent, its patents, trademarks, source code, and proprietary data are pledged, sold, or abandoned by whoever holds the senior claim. Where the IP lands depends on three decisions made long before the shutdown, and almost no founder makes them on purpose. At Beyond Elevation we get the call after the decision is already lost. This post is how to make it early.
What happens to IP when a startup shuts down: it becomes a creditor asset
When a startup shuts down, its IP is treated as property of the failed entity, and that property is distributed to creditors in order of priority. The founders sit at the bottom of that stack, behind the venture debt lender, the bank, unpaid vendors, and often the last bridge investor who took a security interest on the way in.
This surprises people because founders think of patents as theirs. Legally they are the company's, unless the company assigned them somewhere else. So the real question is not who invented the technology. It is who holds the paper on the entity that owns it. In a solvent company nobody checks. In a wind-down it is the only thing that matters.
Who actually gets the patents in a startup insolvency
In a startup insolvency the patents follow one of three paths, and the path is set by paperwork, not merit.
Path one: the secured creditor takes them. If a venture debt lender or a bank has a perfected security interest over company assets, and the company defaults, the lender can foreclose on the IP and sell it to recover the loan. Venture debt in 2026 routinely names the patent portfolio as collateral. That is why understanding patents as collateral before you borrow decides who owns them if the loan goes bad.
Path two: an assignee or trustee sells them. Companies that skip formal bankruptcy often use an Assignment for the Benefit of Creditors, where a third party assignee takes control of every asset and sells it to raise cash for creditors. The assignee has one job: get the highest price fast. They will sell your patents to a competitor, a patent buyer, or whoever bids, and the founders have no veto. This is the same buyer pool described in distressed IP acquisition, where portfolios change hands at steep discounts.
Path three: the IP already lives somewhere else. If the patents were assigned to a separate holding entity before the trouble started, they are not property of the operating company and do not enter the creditor pool at all. This is the clean outcome, and it is only available to founders who structured for it in advance. The mechanics are the same ones covered in the IP holdco structuring guide, with one warning below.
The perfection trap: a UCC-1 does not secure a patent
Here is the mistake that quietly wipes out claims on both sides. A lender or a bridge investor files a UCC-1 financing statement, believes the patents are secured, and relaxes. For US patents a UCC-1 alone is not enough. To perfect a security interest against later buyers, many practitioners record the interest directly with the United States Patent and Trademark Office, because a good-faith purchaser of the patent can otherwise take it free of an unrecorded interest.
The practical result: in a wind-down, an investor who thought they held the IP as collateral discovers a competitor bought the patents clean, and the founder who moved patents into a holdco discovers a poorly documented transfer can be clawed back as a fraudulent conveyance if it happened while the company was already insolvent. Both failures come from treating a patent like a piece of office furniture instead of a recorded asset with its own chain of title. This is exactly what a sharp acquirer hunts for during IP due diligence, and it is why timing and documentation carry more weight than intent.
The salvage move most founders miss: license before you wind down
The highest-value move in a shutdown is not selling the patents after insolvency. It is licensing them out before it. A non-exclusive license granted to a friendly party, a spinout, or the founders' next venture, executed while the company is still solvent and for fair value, creates a revenue interest that can survive the failure of the licensor. A later sale of the underlying patent is often taken subject to that existing license.
Timing is the whole game. Do this while the company is a going concern and it is a legitimate transaction. Do it the week before the assignee arrives and it looks like you stripped value from creditors, which invites a challenge. Founders who wait until the wind-down has started have already lost the option. This is the same logic that separates licensing from selling: a license keeps a claim on future value, a fire sale ends it.
How to protect IP before the wind-down starts
The founders who keep control of their IP through a shutdown all did the same small number of things early:
- Confirm the assignments. Every founder, employee, and contractor should have assigned inventions to the company in writing. Missing assignments mean the company never fully owned the patent, which surfaces at the worst time. The reverse of this same gap is covered in the IP holdco valuation trap.
- Know who holds a security interest. Read your venture debt and bridge documents. If the patents are collateral, model what happens on default before you sign, not after.
- Structure the holdco while solvent. A separate IP entity only protects you if the transfer happened cleanly and for value while the business was healthy. Late transfers get unwound.
- Value the portfolio now. You cannot license, sell, or defend an asset you have never priced. A current valuation is what turns a dying company's patents into a real recovery instead of a giveaway.
Beyond Elevation exists for this exact moment. We have turned many patents into billions in IP value, and the same discipline that raises a valuation in a fundraise is what preserves it in a wind-down. Founders who want the salvage plan built before they need it can start at beyondelevation.com. Our clients rate the work 4.5 on Trustpilot, and the pattern from the DGS data monetization program holds here too: the value was always in the asset, it just needed someone to price it and structure it before the clock ran out.
FAQ
What happens to patents when a startup shuts down?
Patents owned by a shutting-down startup become assets of the failed company and are distributed to creditors by priority. A secured lender can foreclose on them, an assignee or bankruptcy trustee can sell them, or, if they were assigned to a separate holding entity in advance, they may sit outside the creditor pool entirely.
Do founders keep the IP if the company fails?
Usually not. The IP belongs to the company, not the individuals, unless it was formally moved to another entity while the company was solvent. Founders who assume the patents are personally theirs often find a creditor or buyer holds the senior claim.
Can you sell patents during an insolvency?
Yes, and it is common. In an Assignment for the Benefit of Creditors or a Chapter 7 bankruptcy, the assignee or trustee sells the patents to the highest bidder to raise cash for creditors. The founders typically have no control over the price or the buyer.
How do you protect IP before a startup winds down?
Confirm every invention assignment is in writing, know exactly who holds a security interest over the patents, structure any IP holdco while the business is solvent, and get a current valuation. A pre-insolvency license granted for fair value can also preserve a revenue interest that survives the shutdown.
Does a UCC-1 secure a patent as collateral?
Not on its own for US patents. A UCC-1 financing statement covers general assets, but to protect a security interest against a later good-faith purchaser of the patent, the interest is commonly recorded directly with the United States Patent and Trademark Office. Skipping that step is how lenders lose collateral they thought they held.